1. Home
  2. ARMP vs WALD Comparison

ARMP vs WALD Comparison

Compare ARMP & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$5.41

Market Cap

199.7M

Sector

Health Care

ML Signal

HOLD

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$1.33

Market Cap

187.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
WALD
Founded
N/A
1988
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
187.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
ARMP
WALD
Price
$5.41
$1.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$15.00
$2.00
AVG Volume (30 Days)
93.2K
159.2K
Earning Date
05-07-2026
03-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.89
Revenue Next Year
N/A
$4.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$0.72
52 Week High
$14.98
$3.22

Technical Indicators

Market Signals
Indicator
ARMP
WALD
Relative Strength Index (RSI) 55.53 45.05
Support Level $5.12 $1.24
Resistance Level $5.63 $1.83
Average True Range (ATR) 0.47 0.07
MACD 0.08 0.01
Stochastic Oscillator 84.37 45.24

Price Performance

Historical Comparison
ARMP
WALD

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

Share on Social Networks: